Hepatosplenic γδ T-cell lymphoma of two adolescents: Case report and retrospective literature review in children, adolescents, and young adults

Sheila S. McThenia, Jawhar Rawwas, Jennifer Oliveira, Shakila P. Khan, Vilmarie Rodriguez

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

HSTCL is a highly aggressive malignancy with a poor prognosis. Case series and accounts have reported the use of different chemotherapy regimens with diverse patient outcomes. Most long-term survivors had undergone high-dose chemotherapy with autologous or allogeneic HCT. We describe two pediatric patients with HSTCL who were treated with chemotherapy followed by allogeneic HCT. Both patients are alive and in complete remission 2 and 8 years after therapy. Multiagent chemotherapy followed with allogeneic HCT seems to provide patients who have chemotherapy-sensitive disease a long-term disease-free survival.

Original languageEnglish (US)
Article numbere13213
JournalPediatric Transplantation
Volume22
Issue number5
DOIs
StatePublished - Aug 1 2018

Keywords

  • chemotherapy
  • hematopoietic stem cell transplant/bone marrow transplant
  • hepatosplenic T-cell lymphoma

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Fingerprint

Dive into the research topics of 'Hepatosplenic γδ T-cell lymphoma of two adolescents: Case report and retrospective literature review in children, adolescents, and young adults'. Together they form a unique fingerprint.

Cite this